Brooke Eby, a writer, speaker, and social media creator who lives with ALS, has been named ALS Network's Advocate of the Year. Through her advocacy work, Eby has increased awareness and raised more ...

Michele Stellato, 37, and Mira Hudson, 29, are part of a largely unseen group: young women with neurodegenerative disease ALS ...

TAMPA (BLOOM) – November is National Family Caregivers Month and the ALS Association is emphasizing support for ALS caregivers. This November, they are encouraging viewers to share their caregiving ...

DAYTON, Ohio (WDTN) – Hundreds of people walked two miles at Day Air Ball Park to support people living with ALS (Amyotrophic Lateral Sclerosis / Lou Gehrig’s disease) on Sunday morning. The WalkALS ...

ALS is life‑changing, but new treatments, specialized care, and innovative research are bringing real hope. See how advances at University of Utah Health are shaping the future of ALS care.

Rebecca Talley was a strong supporter of the West Texas ALS Support Group and inspired others with her positive outlook ...

BOSTON, Mass. (SHNS)–Nearly 10 years after the ALS Ice Bucket Challenge spurred global awareness about the neurodegenerative disease, patients and doctors on Thursday stressed the need for additional ...

POCATELLO, Idaho (KIFI)– ALS of Nevada is hosting their 'Walk for ALS' in Pocatello to raise awareness and collect donations for research into the deadly disease on Saturday. ALS of Nevada hosted its ...

On Saturday, October 11, 2025, the fight against ALS comes to Marymoor Park in Redmond, WA, with the Walk to Defeat ALS. The walk begins at 11:30 AM, with check-in starting at 10:00 AM, inviting ...

MOBILE, Ala. (WKRG) — ALS is a progressive neurological disorder that affects the motor nerves. USA Health’s Robert Kobelja, M.D., joined WKRG News 5 on The Doctor Is In to discuss the care and ...

ABC11 is inviting the community to join the station's Stogner Strong Team at the Triangle ALS Walk in Raleigh on April 25.

An experimental oral therapy was well-tolerated and linked to lower risks for ALS complications, according to findings of a phase 2b randomized controlled trial published in JAMA Neurology.“The ...